Filing Flows

Filing Flows › United Guardian (UG) › Q1 2026 › vs Q1 2025

United Guardian (UG) Q1 2026 vs Q1 2025 (year over year)

United Guardian's revenue rose $391K (+16%) from $2.5M in Q1 2025 to $2.9M in Q1 2026. The biggest changes: Pharmaceuticals +$277K (+24%); Cosmetic Ingredients +$145K (+21%); Medical −$31K (-5%). Operating margin 22.4% against 24.6% (-2.3 pts).

United Guardian, Q1 2026: revenue $2.9M (+16% year over year), operating margin 22.4%, net earnings $819K, operating cash flow $605K. The chart draws each line against Q1 2025, the increases inside each band.

United Guardian: what changed, Q1 2026 vs Q1 2025United Guardian: what changed, Q1 2026 vs Q1 2025Costs & expenses$360KPre-tax earnings$325KCost of revenue$325KOther income, net$294KOperating cash flow$282KPharmaceuticals$277KFree cash flow (OCF − capex)$276KNet earnings$258KCosmetic Ingredients$145KIncome tax$67K

Margins

Q1 2026Q1 2025Change
Operating margin22.4%24.6%-2.3 pts
Net margin28.5%22.6%+5.9 pts
Free cash flow margin20.7%12.8%+7.9 pts

Every line

LineQ1 2026Q1 2025Change%
Pharmaceuticals$1.4M$1.2M$277K+24%
Cosmetic Ingredients$844K$699K$145K+21%
Medical$583K$614K−$31K-5%
Revenue$2.9M$2.5M$391K+16%
Other income, net$391K$97K$294K+303%
Operating profit$642K$611K$32K+5%
Costs & expenses$2.2M$1.9M$360K+19%
Pre-tax earnings$1.0M$708K$325K+46%
Cost of revenue$1.4M$1.1M$325K+29%
Research & development$115K$114K$1K+0.5%
Other operating costs$667K$633K$34K+5%
Net earnings$819K$561K$258K+46%
Income tax$214K$147K$67K+46%
Depreciation & amortization$29K$25K$4K+16%
Working capital & other$243K$264K−$20K-8%
Operating cash flow$605K$322K$282K+88%
Free cash flow (OCF − capex)$595K$318K$276K+87%
Capital expenditures$10K$4K$6K+174%

Questions

How much did United Guardian's revenue grow year over year in Q1 2026?

United Guardian's revenue rose $391K (+16%) from $2.5M in Q1 2025 to $2.9M in Q1 2026.

What drove United Guardian's revenue change in Q1 2026?

Pharmaceuticals +$277K (+24%); Cosmetic Ingredients +$145K (+21%); Medical −$31K (-5%).

Q1 2026 results → · Compare in the interactive Sankey →